The U.S. Food and Drug Administration’s approval of Rasonque (daraxonrasib) represents an important advance for patients with ...

Salvage radiation given over 26 sessions kept prostate cancer in check as well as the conventional schedule did, according to ...

GYN oncologist Dr. Ami Vaidya, explains what gynecologic cancers are, why awareness matters and how patients can learn to ...

Nona Baker, 40, was raising three children in West Sussex, England, when a hematologist told her she had an incurable blood ...

A friend’s 28-year cancer journey taught one woman how to find hope, stay optimistic and live fully after her own incurable ...

In the phase 2/3 STAR-TREC trial, 78.5% of patients given long-course chemoradiotherapy kept their rectum at 12 months, ...

Lori is also a dedicated mentor to new advanced practice nurses, providing guidance, support and knowledge sharing that helps ...

A testicular cancer survivor shares his story of early detection, embracing failure, and redefining success through hard-won ...

The U.S. Food and Drug Administration (FDA) has approved Rasonque (Daraxonrasib), a once-daily targeted therapy for adults ...

Dolly Parton, the legendary country music singer, songwriter, actress and philanthropist whose influence reached generations ...

The U.S. Food and Drug Administration (FDA) has approved two treatment combinations containing Ziihera (zanidatamab-hrii) for ...

Dr. Shreyas Kalantri, an incoming medical oncologist at the University of Cincinnati, spoke with CURE about what he weighs first when figuring out a treatment plan for a genitourinary (GU) cancer, ...